PRP vs PRP Plus IGF for Patellar Tendinosis
Platelet-rich Plasma Versus Platelet-rich Plasma Plus Concentrated Insulin-like Growth Factor for Patellar Tendinosis: a Randomized Comparative Trial
Sponsor: Ohio State University
Listed as NCT04350827, this NA trial focuses on Patellar Ligament and Platelet-Rich Plasma and remains completed. Sponsored by Ohio State University, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2022 — Nov 2023 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University
For direct contact, visit the study record on ClinicalTrials.gov .